i3 Research

Antidepressant prescriptions in children decrease nearly 10% after warnings were issued

Published in Mental Health Law Weekly, July 15th, 2006

The number of pediatric patients prescribed an antidepressant decreased 9.8% after the U.S. Food and Drug Administration (FDA) issued black-box warnings in October 2004, according to a study being presented by i3 Research at the National Institute of Mental Health's New Clinical Drug Evaluation Unit (NCDEU) annual meeting in Boca Raton.

The study showed the number of patients receiving a selective serotonin reuptake inhibitor (SSRI) or a serotonin-norepinephrine reuptake inhibitor (SNRI) decreased 11.9%.

The FDA issued the black-box warning after a safety review indicated an increased risk of suicide among pediatric antidepressant users. In order to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Mental Health Law Weekly

Source: Mental Health Law Weekly (2006-07-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry